Avalyn Pharma files for Nasdaq IPO

Chronological Source Flow
Back

AI Fusion Summary

Avalyn Pharma, a respiratory drugmaker backed by Novo, has filed for a Nasdaq IPO. Nuclear reactor designer X‑Energy also announced a proposed Nasdaq IPO. Additionally, new buildings are being constructed outside South Station in Boston.
#AVALYN_PHARMA #XENERGY #NASDAQ_IPO #BOSTON_BUILDINGS #NOVO #RESPIROTRIC_DRUGMAKER
08/04 23:04 investing.com
3 Πηγές

Avalyn Pharma files for Nasdaq IPO

Avalyn PharmaNasdaq IPObiotechoncologyimmunologyclinical‑stage
08/04 23:42 bloomberg.com

Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO

08/04 23:50 investing.com

Nuclear reactor designer X-Energy files for proposed Nasdaq IPO

Comments
Loading...
0